Cedar Rapids, IA, United States of America

Lori Manzel


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 60(Granted Patents)


Company Filing History:

goldMedal1 out of 832,843 
Other
 patents

Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Inventor Lori Manzel in Immunology

Introduction: Lori Manzel is an innovative inventor based in Cedar Rapids, Iowa, with a focus on immunology. He holds one patent that demonstrates his commitment to advancing medical science, particularly in the area of immune system modulation.

Latest Patents: Manzel’s patent, titled "Antagonism of immunostimulatory CpG-oligonucleotides by 4-aminoquinolines and other weak bases," explores compositions and methods for inhibiting the stimulation of the immune system. This groundbreaking invention specifically concerns the use of analogs and derivatives of chloroquine, such as 4-aminoquinolines, which can be instrumental in the preventative and therapeutic treatment of autoimmune diseases, transplant rejection, and sepsis.

Career Highlights: Throughout his career, Lori Manzel has focused on innovative solutions within the field of immunology. His research and inventive work signify a strong dedication to addressing complex health challenges and his contributions exemplify the role of inventors in the advancement of medical therapies.

Collaborations: Working alongside notable colleagues, such as Donald E. Macfarlane and Lucjan Strekowski, Manzel's collaborative efforts have further enriched the field of immunology. These partnerships highlight the importance of teamwork in pioneering new inventions and methodologies.

Conclusion: Lori Manzel's contributions to immunology through his innovative patent underscore the vital role of inventors in scientific research and healthcare. His work encourages further exploration and understanding of immune system modulation, representing hope for numerous patients dealing with challenging health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…